You’ll notice it if you stroll through the corridors of nearly every American secondary school: the subtle cup of a hand around a tiny gadget, the persistent cough that parents believe is caused by allergies, and the subtle, sweet chemical odor that lingers near bathroom doors. Adolescents’ use of e-cigarettes spread so swiftly and covertly that the culture changed before the medication did. The industry made them small enough to fit in a shirt pocket, marketed them as a healthier substitute for tobacco, and watched as a whole generation picked them up without realizing—and frequently without being informed—what they were truly inhaling.
Pulmonary doctors are beginning to observe what that exposure looks like inside a body ten years after e-cigarettes became popular. It’s not attractive. The pattern is so familiar to Panagis Galiatsatos, a pulmonary and critical care physician at Johns Hopkins School of Medicine, that he finds it extremely unsettling. Galiatsatos has been treating young vaping patients for a long time. “For most of my patients it starts with something small,” he said. A child who has a persistent cough. bronchitis that comes back. asthma that suddenly becomes more difficult to control. Nothing catastrophic right away, just a gradual deterioration of lung function that develops silently over years before it is impossible to ignore. The addiction is typically well-established by that point.
Key Facts: Vaping & Lung Health — What the Science Says (2025–2026)
| Keys | Values |
|---|---|
| Primary Expert Source | Panagis Galiatsatos, M.D., MHS — Pulmonary & Critical Care Physician, Johns Hopkins School of Medicine |
| Current Youth Vaping Rate (US) | 5.9% of middle and high school students — approximately 1.63 million young people reported current e-cigarette use as of 2024 |
| US Surgeon General Classification | Youth vaping declared a public health crisis |
| Nicotine Content Per Pod | Equivalent to an entire pack of cigarettes — among the highest nicotine delivery mechanisms available |
| E-cigarette Use Growth (US) | 46.6% increase from 2020 to 2022 (CDC data) — one of the fastest-growing substance use trends in recent public health history |
| Conditions Linked to Vaping | Acute bronchitis, recurring lung infections, pneumonia, pneumothorax (lung collapse), bronchiolitis obliterans (“popcorn lung”), EVALI (acute respiratory illness, potentially fatal) |
| Key Chemicals of Concern | Formaldehyde, volatile organic compounds (VOCs), diacetyl (linked to popcorn lung), nicotine — none considered safe for inhalation |
| EVALI | E-cigarette or Vaping product use-Associated Lung Injury — rare but documented fatalities reported; linked primarily to vitamin E acetate in certain cartridges |
| Long-Term Disease Risk | Chronic bronchitis → COPD progression documented in research; emphysema risk considered likely with sustained use based on biological damage patterns |
| Why Damage Is Hidden | Traditional cigarettes take 20–30 years before diseases like COPD or lung cancer manifest; vaping hasn’t been mainstream long enough to reveal its full disease burden |
| Countries With Bans | Thailand bans e-cigarette imports and sales entirely; several countries restrict age of sale, advertising, and flavoring — all showing lower youth use rates |
| Research Scale | Over 50 systematic reviews (primarily 2022–2023) document respiratory, neurological, and cardiovascular damage from e-cigarettes |
Researchers are piecing together a biological picture that is more concerning than the marketing has ever implied. More than fifty systematic reviews, the majority of which were released in 2022 and 2023, show that e-cigarette use causes harm to the neurological, cardiovascular, and respiratory systems. It should come as no surprise that the lungs carry the most weight. Formaldehyde, volatile organic compounds, diacetyl, and heavy metals in certain products are among the chemicals found in vape aerosol that do not belong in lung tissue. They impair the immune response that guards against infection, cause chronic inflammation, and harm the cilia that clear the airway. According to Dr. Galiatsatos, researchers refer to the cumulative effect as “death by a thousand cuts.” Take your time. For years, it was mostly invisible. However, it is taking place.
The analogy to conventional tobacco is instructive and ought to be discussed more extensively than it is. It usually takes 20 to 30 years for conditions like lung cancer, emphysema, or COPD to manifest clinically as a result of cigarette smoking. Because of this delay, tobacco companies maintained for decades that their product was safe; by the time the evidence was clear, they had had a generation to solidify addiction. About ten years ago, e-cigarettes became popular. This indicates that those who began vaping as teenagers are not yet experiencing the worst effects on their lungs. There is inflammation. There is tissue damage. In the clinical perspective of the doctors who treat these patients, the question is not whether the disease will develop, but rather when. The complete reckoning may still be fifteen years off. More people should be afraid of that than they are now.
On their own terms, the early cases—before the long-term disease burden is apparent—are already concerning. In otherwise healthy young adults, pneumothorax, or collapsed lung, is typically rare. Dr. Galiatsatos has worked with young vapers whose vaping seemed to expose a lung vulnerability that had been concealed. EVALI, or e-cigarette or vaping product use-associated lung injury, is a rare but real condition that has claimed lives. Once established, bronchiolitis obliterans, also referred to as “popcorn lung” and associated with the flavoring chemical diacetyl present in certain products, cannot be reversed. Researchers with agendas are not conjuring up these theoretical risks. With the face of a generation that was told the vapor was essentially just water, these clinical presentations are showing up in pulmonology offices and emergency rooms more frequently.

After discovering that 1.63 million middle and high school students were currently using e-cigarettes, the U.S. Surgeon General declared youth vaping to be a public health emergency. In the context of a known lung-damaging product, the 46.6% increase in use in the US between 2020 and 2022 alone is a remarkable failure of public health communication. Measurably lower youth uptake is seen in nations that have imposed stringent restrictions on flavoring and advertising or outright banned the import and sale of e-cigarettes. One example is Thailand. According to the data, regulatory intervention is effective. It also implies that the US has not applied it as quickly as it should have.
As you watch this play out, you get the difficult-to-describe but unavoidable feeling that you are living through a predetermined historical narrative with no control over how it ends. During the 20th century, the tobacco industry funded counter-research, denied early evidence, insisted that its product was safe, and blamed cars and pollution for the lung cancer that its cigarettes were causing.
In his discussion of the vaping industry’s propensity to divert attention away from the more widespread, slower harm caused by regular chemical inhalation while focusing on uncommon, dramatic conditions like popcorn lung, Dr. Galiatsatos made precisely this comparison. It’s the same playbook. The product has a distinct flavor. The younger generation is being conditioned to become addicted to nicotine for the rest of their lives. Although it’s still unclear if the political will to take decisive action will materialize before the disease burden does, the evidence gathered from dozens of peer-reviewed studies makes it clear what will happen.
London Bilingualism's content on health, medicine, and weight loss is solely meant for general educational and informational purposes. This website does not offer any diagnosis, treatment recommendations, or medical advice.
We consistently compile and disseminate the most recent information, findings, and advancements from the medical, health, and weight loss sectors. When content contains opinions, commentary, or viewpoints from professionals, industry leaders, or other people, it is published exactly as it is and reflects those people's opinions rather than London Bilingualism's editorial stance.
We strongly advise all readers to consult a qualified medical professional before acting on any medical, health, dietary, or pharmaceutical information found on this website. Since every person's health situation is different, only a qualified healthcare provider who is familiar with your medical history can offer you advice that is suitable for you.
In a similar vein, any legal, regulatory, or compliance-related information found on this platform is provided solely for informational purposes and should not be used without first obtaining independent legal counsel from a licensed attorney.
You understand and agree that London Bilingualism, its editors, contributors, and affiliated parties are not responsible for any decisions made using the information on this website.
